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Abstract
Background: The phenomenon of hormesis, whereby small amounts of seemingly harmful or
stressful agents can be beneficial for the health and lifespan of laboratory animals has been reported
in literature. In particular, there is accumulating evidence that daily brief cold stress can increase
both numbers and activity of peripheral cytotoxic T lymphocytes and natural killer cells, the major
effectors of adaptive and innate tumor immunity, respectively. This type of regimen (for 8 days) has
been shown to improve survival of mice infected with intracellular parasite Toxoplasma gondii, which
would also be consistent with enhanced cell-mediated immunity.
Presentation of the hypothesis: This paper hypothesizes that brief cold-water stress repeated
daily over many months could enhance anti-tumor immunity and improve survival rate of a non-
lymphoid cancer. The possible mechanism of the non-specific stimulation of cellular immunity by
repeated cold stress appears to involve transient activation of the sympathetic nervous system,
hypothalamic-pituitary-adrenal and hypothalamic-pituitary-thyroid axes, as described in more detail
in the text. Daily moderate cold hydrotherapy is known to reduce pain and does not appear to
have noticeable adverse effects on normal test subjects, although some studies have shown that it
can cause transient arrhythmias in patients with heart problems and can also inhibit humoral
immunity. Sudden immersion in ice-cold water can cause transient pulmonary edema and increase
permeability of the blood-brain barrier, thereby increasing mortality of neurovirulent infections.
Testing the hypothesis: The proposed procedure is an adapted cold swim (5–7 minutes at 20
degrees Celsius, includes gradual adaptation) to be tested on a mouse tumor model. Mortality,
tumor size, and measurements of cellular immunity (numbers and activity of peripheral CD8+ T
lymphocytes and natural killer cells) of the cold-exposed group would be compared to those of
control groups (warm swim and no treatment). Cold-water stress would be administered twice a
day for the duration of several months.
Implications of the hypothesis: If the hypothesis is supported by empirical studies and the
method is shown to be safe, this could lead to the development of an adjunctive immunotherapy
for some (non-lymphoid) cancers, including those caused by viral infections.
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Background
Numerous studies show that small amounts of harmful or
stressful agents (e.g. heat stress, cold stress, hypergravity)
can be beneficial for the health of laboratory animals, the
phenomenon that became known as hormesis, although
evidence for possible benefits in humans is lacking at
present [1,2]. This paper presents theoretical evidence for
immunomodulating properties of brief cold stress, as
increasing evidence indicates that cold stress repeated
daily can have a stimulating effect on cell-mediated
immunity [3-6], while inhibiting humoral immunity to
some extent [7,8]. There is a number of ways to administer
cold stress and this may account for the different effects on
the immune system reported by various studies [9-11].
The focus of this paper is brief whole-body exposure to
cold water since it has been shown to increase both activ-
ity and numbers of peripheral natural killer (NK) cells and
CD8+ T lymphocytes [3,6,12-14]. This effect could be
explained by transient activation of the sympathetic nerv-
ous system (SNS) [15,16], the hypothalamic-pituitary-
adrenal (HPA) axis [17,18] as well as the hypothalamic-
pituitary-thyroid (HPT) axis [19,20] resulting in a brief
action of norepinephrine, adrenocorticotropic hormone
(ACTH), beta-endorphin, and thyroid hormones (triio-
dothyronine (T3) and thyroxine (T4)) on cytotoxic T lym-
phocytes (CTLs) and NK cells. As explained below, all of
these neuroendocrine factors have been previously shown
to promote expansion and/or cytolytic activity of CTLs
and NK cells. Interestingly, brief cold swim stress repeated
for 8 days was also reported to increase survival of mice
infected with intracellular parasite Toxoplasma gondii [5],
the situation that is consistent with enhancement of cellu-
lar immunity. Based on this evidence and given the fact
that NK cells and CTLs are major components of an anti-
tumor immune response [21], it seems logical to propose
the following hypothesis.
Presentation of the hypothesis
The hypothesis is that brief cold-water stress repeated
daily over many months could enhance anti-tumor
immunity and improve cancer survival rate in a mouse
(non-lymphoid) tumor model. While substantial efforts
in the field of tumor immunology are devoted to finding
ways to elicit a tumor-specific CTL response using tumor-
derived antigens [22], this paper discusses a somewhat
different approach of non-specific promotion of cell-
mediated immune responses by increasing the total
number and enhancing cytolytic potential of peripheral
CTLs and NK cells. As a tide that lifts all boats, this
approach could enhance endogenous (but possibly inad-
equate) CTL anti-tumor responses and thereby inhibit the
development and growth of a tumor. Lymphocyte activa-
tion may also lead to autoimmunity, which does not
appear to be the case for immunological changes associ-
ated with repeated cold stress [3,6,12,23,24]. A similar
"broad activation" principle serves as a rationale for sys-
temic interleukin-2 (IL-2) administration, which is cur-
rently used as anti-cancer immunotherapy in renal cell
cancer and metastatic melanoma [25]. However, this
approach proved to be rather inefficient, probably due to
induction of T cell apoptosis and/or inability of the effec-
tor CD8+ T lymphocytes to infiltrate/home to the tumor
site [25,26]. On the other hand, it has been demonstrated
in several mouse tumor models that tumor-specific T cells
are fully mature/activated and effectively infiltrate tumors
but are not able to kill the cognate tumor cells ex vivo due
to defective granule exocytosis-mediated cytotoxicity
[27,28]. This defect is reversible as tumor-specific T cells
that are isolated/purified from the tumor can regain lytic
activity after brief in vitro culture [28]. The paper presented
here hypothesizes that repeated cold stress could induce/
enhance lytic activity of CD8+ T cells at the tumor site,
and may also enhance innate anti-tumor immunity
through expansion and activation of NK cells, all of which
could result in more efficient tumor elimination. The
detailed supporting evidence for this hypothesis is as fol-
lows.
General neuro-endocrine effects of brief cold stress
From available literature, one can distinguish immediate
(or transient) effects of cold stress, lasting 1 to 2 hours,
and longer-term (or sustained) effects of repeated (e.g.
once daily) cold stress, lasting days and possibly weeks.
The immediate/transient effects reported in mice and
humans include: brief activation of the SNS [15,16], of
the HPA axis [17,18] and of the HPT axis [19,20] with a
significant increase in the metabolic rate [29] and in
plasma levels of norepinephrine [15,16], ACTH [30,31],
corticosterone [7], beta-endorphin [18,32], T3 [19,20], T4
[20], as well as a modest or undetectable increase in the
plasma levels of interleukin-6 (IL-6) [12,13] and cortisol
[33,34] (Table 1). The sustained/longer-term effects of
cold stress repeated daily or almost daily (over the period
of 5 days to 6 weeks) appear to include increased plasma
levels of tumor necrosis factor-α (TNF-α) [12], IL-2 [3], IL-
6 [12], ACTH [35], corticosterone [3], as well as a
decreased plasma level of α1-antitrypsin [12] and testo-
sterone [6] (Table 1).
Effects on maturation and peripheral recruitment of CTLs
Brief cold stress such as a cold swim has been reported to
increase the level of peripheral T lymphocytes both in a
transient manner after a single treatment (CD8+ T lym-
phocytes [11]) and in a sustained manner, when treat-
ments are repeated daily or thrice per week (both CD4+
and CD8+ lymphocytes [3,12]). This could be mediated
by the transient action of norepinephrine on β2-adrener-
gic receptors of CD8+ T lymphocytes [36-38] as a result of
the activation of the SNS [39-41], which innervates both
primary and secondary lymphoid organs and can stimu-Infectious Agents and Cancer 2007, 2:20 http://www.infectagentscancer.com/content/2/1/20
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late lymphocyte proliferation, maturation, and peripheral
recruitment via norepinephrine release in a non-synaptic
fashion (reviewed in [42]). Additionally, the cold stress-
induced expansion of CTLs could be mediated by changes
in other neuroendocrine factors that are known to be
caused by cold stress (Table 2).
Effects on activity of CTLs
Studies show that both single and repeated (daily) brief
exposure to cold can enhance antigen-induced prolifera-
tive responses of T lymphocytes and the level of activated
peripheral T lymphocytes in mammals [3,4,6,12,14]. This
stimulatory effect could be mediated by the brief action of
the SNS (via norepinephrine), of beta-endorphin, T3, or
T4 or sustained action of ACTH and IL-2 (Table 2). There
is also evidence of an increased phagocytic index follow-
ing brief cold stress [43], suggesting that antigen (cross-
)presentation may be enhanced. Unfortunately, it is not
known if cold stress can enhance cytolytic activity of
peripheral cytotoxic T lymphocytes, but there is indirect
evidence that this may be the case (Table 2 and [5,24]).
Table 1: Known effects of cold stress. "Immediate/transient" means effects of a single brief exposure to cold that last less than 1–2 
hours. "Sustained/longer-term" means effects (of repeated daily or several times per week cold-water stress) that can last one day or 
longer.
Immediate/transient effects Sustained/longer-term effects
Activation of:
sympathetic nervous system [15,16]
hypothalamic-pituitary-adrenal axis [17,18]
hypothalamic-pituitary-thyroid axis [19,20]
Increased resting metabolic rate [29]
An increase in plasma levels of:
adrenocorticotropic hormone [35]
corticosterone* [3]
interleukin-2 (modest/undetectable) [3,84]
interleukin-6 [12]
tumor necrosis factor-α [12]
haptoglobin [12]
hemopexin [12]
An increase in plasma levels of:
adrenocorticotropic hormone [30,31]
norepinephrine [15,16]
beta-endorphin [18,32]
corticosterone* [7]
cortisol (modest/undetectable) [33,34,82,83]
thyroid stimulating hormone [20]
triiodothyronine [19,20]
thyroxine [20]
interleukin-6 [6,13]
Decreased plasma level of interleukin-2 [84,85]
Decreased plasma levels of:
α1-antitrypsin [12]
testosterone [6]
* It is expected to have a negligible immunosuppressive effect [86,87].
Table 2: Possible mechanisms underlying the stimulatory effects of repeated cold stress on cell-mediated immunity
CTLs and other cytotoxic immune cells NK cells*
Expansion/peripheral recruitment brief action** of the SNS [39-41] (via norepinephrine) 
on β2-adrenergic receptors of CD8+ T lymphocytes 
[36-38]; elevated plasma levels of ACTH [88,89], T4 
[90], and beta-endorphin [91];
brief action** of the SNS (via norepinephrine) on β2-
adrenergic receptors of NK cells [37,42,44]; 
upregulation of beta-endorphin [92], IL-2 [93], T3 
[94] and T4 [95];
Activation brief action** of the SNS (via norepinephrine) 
[36,39,96-98], beta-endorphin [91,99-101], T3 [102], 
or T4 [90,103,104] or sustained action of ACTH 
[88]; increased phagocytic index [43], downregulation 
of testosterone [105-107] or α1-antitrypsin [108];
-
Cytolytic activity upregulation of ACTH [88,89], beta-endorphin 
[109,110], IL-2 [111-113], IL-6 [114,115], TNF-α 
[116-118], combination of IL-2 + IL-6 [119,120], or 
IL-2 + TNF-α [121]; downregulation of α1-
antitrypsin [122,123];
elevated plasma levels of IL-2 [93], beta-endorphin 
[124-126], ACTH [127,128], T3 [129,130] or T4 
[131,132];
* Continuous hypothermia [133] (lowered core body temperature which cannot normally result from a brief exposure to cold in most mammals 
[52,53]) or continuous exposure to acute cold (4 hours or longer [134]) have been shown to reduce both the number and activity of peripheral NK 
cells.
** Continuous elevated levels of norepinephrine or other β2-adrenergic agonists (3 hours or longer) appear to have an opposite effect: reduction 
in peripheral CTLs and NK cells and inhibition of their activity [42,135,136].Infectious Agents and Cancer 2007, 2:20 http://www.infectagentscancer.com/content/2/1/20
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Effects on maturation and peripheral recruitment of NK 
cells
Single brief exposure to cold appears to transiently
increase the level of peripheral NK cells [11,13]. This
could be due to the increased peripheral recruitment and/
or expansion of these cells, which are known to be medi-
ated by the action of the SNS (via norepinephrine) on β2-
adrenergic receptors of NK cells [37,42,44]. This effect
could also be mediated by elevated levels of beta-endor-
phin, IL-2, T3 and T4 (Table 2).
Effects on activity of NK cells
Both single and repeated (daily) brief cold stress has been
shown to enhance cytolytic activity of NK cells [3,13]. This
could be the result of elevated plasma levels of IL-2, beta-
endorphin, ACTH, T3 or T4 (Table 2).
Other effects
Daily moderate cold water stress does not appear to have
noticeable adverse effects on normal test subjects either
short-term or long-term [12,15,24,45] and, interestingly,
in a near-life-time experiment on healthy rats, where the
animals had to stand in 23°C water 4 hours per day 5 days
per week, the repeated cold stress extended the lifespan by
statistically insignificant 5% and somewhat reduced spon-
taneous incidence of tumors, especially sarcomas [24].
Based on the evidence presented earlier, more frequent
exposure to cold of shorter duration, for example 5-
minute cold swim stress twice per day (>7 hours apart),
could have a more significant immunostimulatory effect
and a less pronounced effect on metabolism compared to
the above experiment. Cold water stress is also known to
have an analgesic effect [32,46,47], which is often relevant
in cancer.
Possible adverse effects
1) Water colder than 14°C can cause cutaneous pain
[48,49] and therefore would be best avoided.
2) Exposure to acute cold for extended periods of time can
cause a significant drop of core body temperature (hypo-
thermia) which can be associated with such adverse effects
on health as ataxia, hypovolemia, atrial dysrhythmias,
cold diuresis, and mental confusion [50,51]. Immersion
in moderately cold water in the range of 16–23°C does
not appear to cause hypothermia (core temperature of
35°C or lower) in healthy human subjects, even when it
lasts for several hours [52]. During this procedure, core
body temperature stays virtually unchanged during the
first hour [52] due to unusual efficiency of the human
thermoregulatory system [53]. It should be noted that the
elderly or people with certain metabolic disorders may
develop hypothermia under these conditions, and thus
body temperature should be monitored in these groups of
people if they use cold hydrotherapy [50,51].
3) Coldest months of the year have been shown to be
associated with a higher incidence of acute heart failure
and stroke [54-56]. In the landmark experiment by Hol-
loszy and Smith described above, where rats were stand-
ing in cold water 4 hours per day, the prevalence of
cardiovascular problems was increased according to post-
mortem examination, although the average lifespan was
increased insignificantly and the prevalence of malignan-
cies declined [24]. It is not known if daily brief exposure to
moderately cold water (20°C, under 15 minutes) with
gradual adaptation will have similar cardiovascular effects
in the long run. Studies also show that immersion in cold
water can cause transient arrhythmias in some patients
with heart problems [57-59], although short-term cardio-
vascular effects of cold water immersion seem to be
benign in normal test subjects [15].
4) Upper respiratory tract infections such as the flu and
common cold occur predominantly although not exclu-
sively during the cold time of the year, i.e. late fall/winter
[60]. It is not known if this is due to exposure to cold, die-
tary patterns, or some other factors [61]. Near-life-time
exposure of rats to cold water (23°C) for several hours per
day was not reported to increase incidence of respiratory
infections [24], as was the case for 1-hour cold water
immersions (14°C) repeated 3 times per week for 6 weeks
in humans [12,15]. On the other hand, some studies
show that inhalation of cold air can inhibit cell-mediated
immunity in the mucosa of the respiratory tract and thus
possibly increase susceptibility to respiratory viral infec-
tions [62].
5) Swimming in ice-cold water can cause transient pulmo-
nary edema in humans [63-65], which may be due to
severe hypothermia among other things [51].
6) Some studies show that sudden immersion in ice-cold
water can increase permeability of the blood-brain barrier
in mice [66,67], and when repeated daily can also increase
mortality of neurovirulent infections (e.g. West Nile virus,
Sindbis virus) due to propagation of the infection to the
brain of the mice [68,69]. Increased permeability of the
blood-brain barrier can be due to the distress associated
with a dive into ice-cold water because a different treat-
ment which also causes distress to the animals, namely,
isolation, has very similar adverse effects [67]. In addition,
immersion in ice-cold water can rapidly cause severe
hypothermia in mice [70] and hypothermia is known to
increase permeability of the blood brain barrier in healthy
animals [71]. The proposed adapted cold swim procedure
at 20°C is not expected to compromise the blood-brain
barrier in mice because it is designed to be minimally
stressful (contains a gradual adaptation phase) and is
brief, such that the core body temperature of the animals
would remain above 35°C. The methods described in theInfectious Agents and Cancer 2007, 2:20 http://www.infectagentscancer.com/content/2/1/20
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"Testing the hypothesis" section could verify this assump-
tion.
In summary, the review of literature suggests that winter
swimming (in other words, sudden immersion in ice-cold
water) may pose serious risks to health and it is possible
that exposure to cold can be safer if it is brief and does not
involve psychological distress, inhalation of cold air, and
hypothermia. Further studies would be needed to assess
the safety of the relatively non-stressful regimen of cold
hydrotherapy that is proposed in this paper. At the same
time, minimally stressful exposure to moderate cold still
seems to have significant physiological and immunologi-
cal effects [6,13,33,34], which may be useful for enhanc-
ing anti-tumor immunity according to our hypothesis.
Testing the hypothesis
The hypothesis can be tested using a treatment that con-
sists of an adapted cold swim procedure which begins
with a slow and gradual lowering of a cage with laboratory
animals into stirred cold water (20°C) over the period of
4–5 minutes followed by a 1- or 2-minute cold swim. The
adaptation phase is expected to minimize stress and dis-
comfort for the animals. The cage would be lifted out of
the water to discontinue cold exposure and placed on
proper bedding (certain cooling may still occur due to
subsequent evaporation of water from the fur of the ani-
mals). The procedure is estimated to cause the core body
temperature of mice to decline by approximately 2°C
based on data from Wan R. et al. [70], and may have to be
tested and optimized in order to avoid inducing signifi-
cant hypothermia in the animals. Manual handling of
individual mice would be best avoided. Cold water stress
would be administered twice per day (more than 7 hours
apart) according to a schedule described below. A syn-
geneic orthotopic mouse tumor model can be tested, for
example, intradermal injection of MEB4 melanoma cell
line (4 × 104 cells) in C57BL/6 mice [72] or subcutaneous
injection of 6-1 tumor cell line (2 × 105 cells) in C3H/HeN
mice [73]. Sixty mice can be used for a single experiment
and all of them would be injected with tumor cells. One
third of the animals will be assigned to the cold swim
group. The other mice will be divided into two control
groups: a warm swim group (Control I) and the no treat-
ment group (Control II). Control I group will undergo
adapted warm swim procedures (water temperature is
37°C) simultaneously with the cold swim (experimental)
group. Control II group will undergo handling of the cage
(and, possibly, manual handling of animals) similar to
the experimental and Control I groups, but without
immersion in water. Cold water stress would be initiated
2 weeks prior to injection of tumor cells and would be
stopped for 3 days immediately after the inoculation in
order to allow the skin wounds to close. Then cold water
treatments would be resumed and continued for 2
months. On weekends, only one swim or, alternatively,
no swims at all would be performed. At approximately 60
days postinjection, mortality, tumor incidence, and tumor
size would be assessed in all three groups [72]. In addi-
tion, the numbers and cytolytic activity of peripheral NK
cells [74-76] as well as average numbers of CD25-positive
(activated) and total peripheral CD4+ T lymphocytes and
CD8+ T lymphocytes [77,78] and their effector properties
(i.e., TCR-induced cytokine production [79] and lytic
function [28]) would be measured before initiation of
cold water treatment (in 5–10 mice) and 60 days after the
tumor inoculation in the experimental and control groups
of mice. In a separate group of 10–20 tumor-injected
mice, lytic activity of freshly isolated CD8+ tumor infil-
trating (and peripheral) T lymphocytes would be assessed
as a function of time after the initiation of cold stress treat-
ment [28,73].
To verify if the proposed cold stress procedure does not
significantly increase permeability of the blood-brain bar-
rier in the animals, an Evans blue extravasation assay
[80,81] can be performed in an additional small group of
mice with a no-treatment control.
If the adapted cold swim is shown to be beneficial and
safe in mouse tumor models, a similar regimen can be
tested on human subjects, namely, adapted cold showers,
20°C, 2–5 minutes, preceded by a 5-minute gradual adap-
tation phase (expansion of the area of contact with water
from the feet up), performed twice per day (morning and
afternoon). The shower format is preferable in humans
because the setup appears to take less time and effort com-
pared to cold baths.
Implications of the hypothesis
If the theory is confirmed by empirical studies and the
proposed approach is shown to be safe, then some form
of cold hydrotherapy could potentially become a treat-
ment option for some (non-lymphoid) cancers as an
adjunctive immunotherapy.
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